TS
GBIO

Thomas Steyer’s Generation Bio GBIO Stock Holding History

Thomas Steyer’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-124,938
Closed -$4.91M – 199
2022
Q4 		$4.91M Sell
124,938
-125,062
-50% -$6.57M 0.03% 146
2022
Q3 		$13.3M Sell
250,000
-39,730
-14% -$2.49M 0.07% 118
2022
Q2 		$19M Sell
289,730
-60,270
-17% -$3.94M 0.1% 100
2022
Q1 		$25.7M Hold
350,000
– – 0.12% 89
2021
Q4 		$24.8M Hold
350,000
– – 0.12% 84
2021
Q3 		$87.7M Hold
350,000
– – 0.41% 57
2021
Q2 		$94.2M Buy
350,000
+22,950
+7% +$6.87M 0.38% 56
2021
Q1 		$93.1M Buy
327,050
+100,168
+44% +$32.1M 0.46% 52
2020
Q4 		$64.3M Buy
226,882
+14,819
+7% +$4.76M 0.39% 59
2020
Q3 		$65.5M Buy
212,063
+181
+0.1% +$43.3K 0.45% 56
2020
Q2 		$44.5M Buy
+211,882
New +$47.2M 0.36% 58

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Thomas Steyer's GBIO Position: Q1 2023 in Review

Thomas Steyer sold out of Generation Bio (GBIO) in Q1 2023, closing a stake of 124,938 shares — an estimated $4.91M sold.

Thomas Steyer first reported a position in GBIO in Q2 2020 and held it in 11 quarters. The position peaked at $94.2M in Q2 2021. 83 funds tracked by Wall St. Rank hold GBIO as of Q1 2023.

  • Thomas Steyer reported no remaining Generation Bio position as of Q1 2023 after selling out during the quarter.
  • Thomas Steyer sold 124,938 Generation Bio shares in Q1 2023, an estimated $4.91M.
  • Thomas Steyer first reported a position in Generation Bio in Q2 2020 and held it in 11 quarters.
  • Thomas Steyer's Generation Bio position peaked at $94.2M in Q2 2021.
  • 83 funds tracked by Wall St. Rank held Generation Bio as of Q1 2023.

Based on Farallon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.